Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF) Short Interest Up 31.6% in March

Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXFGet Free Report) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 5,000 shares, a growth of 31.6% from the February 29th total of 3,800 shares. Based on an average daily volume of 3,100 shares, the days-to-cover ratio is currently 1.6 days.

Eupraxia Pharmaceuticals Stock Performance

Shares of EPRXF stock opened at C$3.24 on Monday. The stock’s fifty day simple moving average is C$4.28 and its 200 day simple moving average is C$4.38. Eupraxia Pharmaceuticals has a twelve month low of C$2.93 and a twelve month high of C$6.78.

About Eupraxia Pharmaceuticals

(Get Free Report)

Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.

Featured Articles

Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.